Effects of High Dose Opioids and Sedatives on Survival in Terminally Ill Cancer Patients

Chemy, 1994, Sedation in the management of refractory symptoms, J Palliat Care, 10, 31, 10.1177/082585979401000207 Fainsinger, 1991, Symptom control during the last week of life on a palliative care unit, J Palliat Care, 7, 5, 10.1177/082585979100700102 Fainsinger, 1998, Sedation for uncontrolled symptoms in a South African hospice, J Pain Symptom Manage, 16, 145, 10.1016/S0885-3924(98)00066-9 Lichter, 1990, The last 48 hours of life, J Palliat Care, 6, 7, 10.1177/082585979000600403 Morita, 1996, Sedation for symptom control in Japan, J Pain Symptom Manage, 12, 32, 10.1016/0885-3924(96)00046-2 Stone, 1997, A comparison of the use of sedatives in a hospital support team and in a hospice, Palliat Med, 11, 140, 10.1177/026921639701100208 Ventafridda, 1990, Symptom prevalence and control during cancer patients' last days of life, J Palliat Care, 6, 7, 10.1177/082585979000600303 Chater, 1998, Sedation for intractable distress in the dying—a survey of experts, Palliat Med, 12, 255, 10.1191/026921698671831786 Fondras, 1996, Sedation and ethical contradiction, Eur J Palliat Care, 3, 17 Morita, 1999, Do hospice clinicians sedate patients intending to hasten death?, J Palliat Care, 15, 20, 10.1177/082585979901500305 Morita, 1999, Survival prediction of terminally ill cancer patients by clinical symptoms, Japan J Clin Oncol, 29, 156, 10.1093/jjco/29.3.156 Anderson, 1996, Palliative Performance Scale (PPS), J Palliat Care, 12, 5, 10.1177/082585979601200102 Morita, 1999, The Palliative Prognostic Index, Support Care Cancer, 7, 128, 10.1007/s005200050242 1994 Breitbart, 1998, Psychiatric aspects of palliative care, 932 Hanks, 1998, Opioid analgesic therapy, 331 Dundee, 1984, Midazolam. A review of its pharmacological properties and therapeutic use, Drugs, 28, 519, 10.2165/00003495-198428060-00002 Kasama, 1983, Pharmacological action of bromazepam suppository, Folia Pharmacol Japon, 81, 149, 10.1254/fpj.81.149 Moolenaar, 1980, Biopharmaceutis of rectal administration of drugs in man IV. Comparative biopharmaceutics of diazepam after single rectal, oral, intramascular, and intravenous administration in man, Int J Pharmaceutics, 5, 127, 10.1016/0378-5173(80)90017-4 Bercovitch, 1999, High dose morphine use in the hospice setting. A database survey of patient characteristics and effect on life expectancy, Cancer, 86, 871, 10.1002/(SICI)1097-0142(19990901)86:5<871::AID-CNCR25>3.0.CO;2-L Coyle, 1990, Character of terminal illness in the advanced cancer patient, J Pain Symptom Manage, 5, 83, 10.1016/S0885-3924(05)80021-1 Lombard, 1989, The use of opioid analgesics in the last 24 hours of life of patients with advanced cancer, Palliat Med, 3, 27, 10.1177/026921638900300105 Amesbury, 1989, The use of subcutaneous midazolam in the home care setting, Palliat Med, 3, 299, 10.1177/026921638900300411 Bottomely, 1990, Subcutaneous midazolam infusion in palliative care, J Pain Symptom Manage, 5, 259, 10.1016/0885-3924(90)90020-K Burke, 1991, Terminal restlessness—its management and the role of midazolam, Med J Aust, 155, 485, 10.5694/j.1326-5377.1991.tb93848.x de Sousa, 1988, Midazolam in terminal care, Lancet, 1, 67, 10.1016/S0140-6736(88)91057-4 Gremaud, 1998, Indications and limitations of intravenous and subcutaneous midazolam in palliative care center, J Pain Symptom Manage, 15, 331, 10.1016/S0885-3924(98)00020-7 Holdsworth, 1995, Continuous midazolam infusion for the management of morphine-induced myoclonus, Ann Pharmacother, 29, 25, 10.1177/106002809502900105 McNamara, 1991, Use of midazolam in palliative care, Palliat Med, 5, 244, 10.1177/026921639100500310 Ramani, 1996, Long-term subcutaneous infusion of midazolam for refractory delirium in terminal breast cancer, South Med J, 89, 1101, 10.1097/00007611-199611000-00017 Sanders, 1996, Discomfort and pain associated with paratonia, Eur J Palliat Care, 3, 54 Smales, 1989, Flunitrazepam in terminal care, Lancet, 2, 501, 10.1016/S0140-6736(89)92107-7 McIver, 1994, The use of chlorpromazine for symptom control in dying cancer patients, J Pain Symptom Manage, 9, 341, 10.1016/0885-3924(94)90193-7 Stirling, 1999, The use of phenobarbitone in the management of agitation and seizures at the end of life, J Pain Symptom Manage, 17, 363, 10.1016/S0885-3924(99)00006-8 Greene, 1991, Titrated intravenous barbiturates in the control of symptoms in patients with terminal cancer, South Med J, 84, 332, 10.1097/00007611-199103000-00009 Mercadante, 1999, Propofol in terminal care, J Pain Symptom Manage, 10, 639, 10.1016/0885-3924(95)00131-X Moyle, 1995, The use of propofol in palliative medicine, J Pain Symptom Manage, 10, 643, 10.1016/0885-3924(95)00125-5 Akechi, 1996, Usage of haloperidol for delirium in cancer patients, Support Care Cancer, 4, 390, 10.1007/BF01788847 Breitbart, 1996, A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients, Am J Psychiatry, 153, 231, 10.1176/ajp.153.2.231